STOCK TITAN

Accuray to Report First Quarter Fiscal 2023 Financial Results on November 2, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Accuray Incorporated (NASDAQ: ARAY) will announce its financial results for the first quarter of fiscal year 2023, which concludes on September 30, 2022, after market close on November 2, 2022. Following the release, management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results. The call can be accessed via dial-in numbers or through a live webcast on their Investor Relations website.

Accuray is focused on innovative radiation therapy solutions for oncology and neuro-radiosurgery, aiming to enhance patient outcomes.

Positive
  • None.
Negative
  • None.

SUNNYVALE, Calif., Oct. 19, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2023, ended September 30, 2022, after the market close on November 2, 2022. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m. ET on the same day.

The conference call dial-in numbers are (833) 316-0563 (USA) or (412) 317-5747 (International). In addition, a dial up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is (877) 344-7529 (USA), or (412) 317-0088 (International), Conference ID: 7880143.

A live webcast of the call will also be available from the Investor Relations section of the Company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the second quarter of fiscal 2023.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter, and YouTube.

Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com

Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-first-quarter-fiscal-2023-financial-results-on-november-2-2022-301653489.html

SOURCE Accuray Incorporated

FAQ

When will Accuray report its Q1 fiscal 2023 financial results?

Accuray will report its financial results for the first quarter of fiscal year 2023 on November 2, 2022.

What time is Accuray's conference call for Q1 fiscal 2023 results?

The conference call will take place at 1:30 p.m. PT / 4:30 p.m. ET on November 2, 2022.

How can I access the live webcast of Accuray's conference call?

The live webcast can be accessed from the Investor Relations section of Accuray's website.

What is the fiscal year end date for Accuray's Q1 2023?

Accuray's first quarter of fiscal year 2023 ends on September 30, 2022.

Accuray Incorporated

NASDAQ:ARAY

ARAY Rankings

ARAY Latest News

ARAY Stock Data

176.42M
100.57M
2.87%
60.7%
4.01%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
MADISON